Literature DB >> 25554827

Diethylaminobenzaldehyde is a covalent, irreversible inactivator of ALDH7A1.

Min Luo1, Kent S Gates1, Michael T Henzl2, John J Tanner1,2.   

Abstract

There is growing interest in aldehyde dehydrogenases (ALDHs) because of their overexpression in cancer stem cells and the ability to mediate resistance to cancer drugs. Here, we report the first crystal structure of an aldehyde dehydrogenase complexed with the inhibitor 4-diethylaminobenzaldehyde (DEAB). Contrary to the widely held belief that DEAB is a reversible inhibitor of ALDHs, we show that DEAB irreversibly inactivates ALDH7A1 via formation of a stable, covalent acyl-enzyme species.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25554827     DOI: 10.1021/cb500977q

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  24 in total

1.  Impact of disease-Linked mutations targeting the oligomerization interfaces of aldehyde dehydrogenase 7A1.

Authors:  David A Korasick; John J Tanner; Michael T Henzl
Journal:  Chem Biol Interact       Date:  2017-01-10       Impact factor: 5.192

2.  Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1.

Authors:  Jesse W Wyatt; David A Korasick; Insaf A Qureshi; Ashley C Campbell; Kent S Gates; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2020-07-24       Impact factor: 4.013

3.  Metabolic enzymes expressed by cancer cells impact the immune infiltrate.

Authors:  Gautier Stoll; Margerie Kremer; Normal Bloy; Adrien Joseph; Maria Castedo; Guillaume Meurice; Christophe Klein; Lorenzo Galluzzi; Judith Michels; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

Review 4.  Structure, function, and mechanism of proline utilization A (PutA).

Authors:  Li-Kai Liu; Donald F Becker; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2017-07-14       Impact factor: 4.013

5.  Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.

Authors:  Angelica R Harper; Anh T Le; Timothy Mather; Anthony Burgett; William Berry; Jody A Summers
Journal:  Bioorg Med Chem       Date:  2018-10-24       Impact factor: 3.641

6.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

7.  Importance of the C-Terminus of Aldehyde Dehydrogenase 7A1 for Oligomerization and Catalytic Activity.

Authors:  David A Korasick; Jesse W Wyatt; Min Luo; Adrian R Laciak; Kasi Ruddraraju; Kent S Gates; Michael T Henzl; John J Tanner
Journal:  Biochemistry       Date:  2017-11-07       Impact factor: 3.162

8.  Crystal Structure of Aldehyde Dehydrogenase 16 Reveals Trans-Hierarchical Structural Similarity and a New Dimer.

Authors:  Li-Kai Liu; John J Tanner
Journal:  J Mol Biol       Date:  2018-12-07       Impact factor: 5.469

9.  Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.

Authors:  Zhen Huang; Daisuke Ogasawara; Uthpala I Seneviratne; Armand B Cognetta; Christopher W Am Ende; Deane M Nason; Kimberly Lapham; John Litchfield; Douglas S Johnson; Benjamin F Cravatt
Journal:  ACS Chem Biol       Date:  2019-01-31       Impact factor: 5.100

Review 10.  Structural Biology of Proline Catabolic Enzymes.

Authors:  John J Tanner
Journal:  Antioxid Redox Signal       Date:  2017-11-13       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.